Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Scutellaria baicalensis is a perennial flowering plant native to East Asia and widely used in traditional Chinese medicine (TCM) for over 2,000 years. The dried root—known as Huang Qin—is a key ingredient in many TCM formulas for treating conditions such as hepatitis, respiratory infections, inflammation, cancer, liver disease, anxiety, and insomnia[1][5][6][9]. Its pharmacological effects are attributed mainly to its bioactive flavonoids (baicalin, wogonin, and baicalein), which exhibit anti-inflammatory, antioxidant, antibacterial/antiviral activity; neuroprotective effects; anticancer properties via apoptosis induction and cell cycle arrest; modulation of neurotransmitters; immune enhancement; and potential hepatoprotective actions[1][3][6][7][8]. Mechanistically these compounds act on multiple molecular targets including GABA receptors (modulating CNS activity), solute carrier transporters (affecting drug absorption/metabolism), heat shock protein 90 (HSP90), JUN/RELA/AKT1 signaling pathways in cancer cells[1][7]. Modern research supports its multi-targeted action profile but robust clinical evidence remains limited. It is available as herbal teas/extracts/capsules/powders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on scutellaria baicalensis.